Fig. 2
From: Phytogalactolipids activate humoral immunity against colorectal cancer
Titers and recognition of CRA-induced anti-tumor antibodies. Panel A. Titers of specific anti-CT26.CL25 cell antibodies for control or CRA antisera on days 0 and 33. Panel B. Effects of CRA on the class-switch of specific anti-CT26 cell antibodies. The titers of these antisera (1,000 × dilution) were measured for IgM, IgG1, IgG2a, IgG2b, IgG3, and IgA. Panel C. Tumor specificity of CRA antisera. Normal sera, control antisera, or CRA antisera bound to CT26.CL25 (black bar) or MG-CAP-A1 cells (white bar) were indirectly detected with FITC-conjugated goat anti-mouse IgG antibody